Experimental Prostate Treatment

A new Israeli development for the reduction of an enlarged prostate in ten minutes was performed for the first time in Israel at Ziv Medical Center.

The prostate gland is a male reproductive organ surrounding the urethra just beneath the bladder. Its main function is to secrete prostate fluid, one of the components of semen, which is propelled into the urethra during ejaculation. A swollen prostate compresses the urethra and irritates the walls of the bladder, interfering with normal urination.

 About 40% of men over the age of 50 suffer from Benign Prostate Hyperplasia (BPH) or enlarged prostate, and after age 60 the incidence increases to 70% or more. There are today a variety of treatments for urinary incontinence resulting from an enlarged prostate, the most common of which is medication that constricts the gland.  In cases where this is not effective, patients are generally referred for surgery.  An alternative to surgery has been the use of a stent, inserted into the urethra to prevent it from rupturing. This however has its own problems.

The Israeli start-up “Butterfly Medical” has developed a new, smaller, butterfly-shaped stent, which can be inserted in under 10 minutes, in-office, under local anesthesia, without surgical incision, heating or prostate tissue removal. The device aims to be the only in-office BPH treatment that delivers a long-term, effective solution with minimal side effects, requiring no hospitalization or general anesthesia and is a superior alternative to existing BPH minimally invasive treatments. The treatment is reversible and the stent can be removed at any stage. Early results from clinical trials are very promising with blocked urethras successfully opened and patients suffering no side effects.
Three patients were recently successfully treated at Ziv with this new device. The hospital invites those interested in undergoing the stent implantation to call and check if they are appropriate candidates for the procedure, which is not suitable for those who have already had surgery, are suffering from prostate cancer, have undergone radiation or suffering from protrusions of the prostate. During the trial period, treatment will be free of charge to suitable candidates.